4//SEC Filing
THOMSON DAVID S. 4
Accession 0001209191-21-040570
CIK 0001357874other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:19 PM ET
Size
9.2 KB
Accession
0001209191-21-040570
Insider Transaction Report
Form 4
THOMSON DAVID S.
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-11$1.18/sh+30,000$35,400→ 141,513 total - Sale
Common Stock
2021-06-11$11.52/sh−30,000$345,600→ 111,513 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-06-11−30,000→ 87,113 totalExercise: $1.18Exp: 2027-06-29→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Includes 2,270 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 25, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $11.68. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001770315
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:19 PM ET
- Size
- 9.2 KB